Gene · 4607
Papers3,985
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,985
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical exome sequencing unravels the diverse spectrum of genetic heterogeneity and genotype-phenotype correlations in hypertrophic cardiomyopathy. | Int J Cardiol | 2024 | 38880420 | PubTator, text mining | PubMed |
| Phenotypic spectrum of the first Belgian MYBPC3 founder: a large multi-exon deletion with a varying phenotype. | Front Genet | 2024 | 38836037 | PubTator, text mining | PubMed |
| Substrate mechanics unveil early structural and functional pathology in iPSC micro-tissue models of hypertrophic cardiomyopathy. | iScience | 2024 | 38827401 | PubTator, text mining | PubMed |
| Atrial Fibrillation Substrate and Catheter Ablation Outcomes in MYBPC3- and MYH7-Mediated Hypertrophic Cardiomyopathy. | JACC Clin Electrophysiol | 2024 | 38819352 | PubTator, text mining | PubMed |
| Sudden Cardiac Death, Post-Mortem Investigation: A Proposing Panel of First Line and Second Line Genetic Tests. | J Pers Med | 2024 | 38793126 | PubTator, text mining | PubMed |
| Cardiac genetic test yields and genotype-phenotype correlations from large cohort investigated by medical examiner's office. | Cardiovasc Pathol | 2024 | 38777137 | PubTator, text mining | PubMed |
| Generation of induced pluripotent stem cells from an individual with early onset and severe hypertrophic cardiomyopathy linked to MYBPC3: c.772G > A mutation. | Hum Cell | 2024 | 38762696 | PubTator, text mining | PubMed |
| Genomics and insurance in the United Kingdom: increasing complexity and emerging challenges. | Health Econ Policy Law | 2024 | 38752549 | PubTator, text mining | PubMed |
| Multinational experience with next-generation sequencing: opportunity to identify transthyretin cardiac amyloidosis and Fabry disease. | Cardiovasc Diagn Ther | 2024 | 38716318 | PubTator, text mining | PubMed |
| Insights into the Novel Cardiac Biomarker in Acute Heart Failure: Mybp-C. | Life (Basel) | 2024 | 38672783 | PubTator, text mining | PubMed |
| MYBPC3-c.772G>A mutation results in haploinsufficiency and altered myosin cycling kinetics in a patient induced stem cell derived cardiomyocyte model of hypertrophic cardiomyopathy. | J Mol Cell Cardiol | 2024 | 38648963 | PubTator, text mining | PubMed |
| Myosin inhibitor reverses hypertrophic cardiomyopathy in genotypically diverse pediatric iPSC-cardiomyocytes to mirror variant correction. | Cell Rep Med | 2024 | 38642550 | PubTator, text mining | PubMed |
| Biomarkers to predict improvement of left ventricular ejection fraction after atrial fibrillation ablation. | Heart Rhythm | 2024 | 38614192 | PubTator, text mining | PubMed |
| Whole genome sequencing in paediatric channelopathy and cardiomyopathy. | Front Cardiovasc Med | 2024 | 38586174 | PubTator, text mining | PubMed |
| Investigation of mutation spectrum amongst patients with familial primary cardiomyopathy using targeted NGS in Indian population. | J Appl Genet | 2024 | 38551768 | PubTator, text mining | PubMed |
| Role of Genetics in Diagnosis and Management of Hypertrophic Cardiomyopathy: A Glimpse into the Future. | Biomedicines | 2024 | 38540296 | PubTator, text mining | PubMed |
| Myosin-binding protein C regulates the sarcomere lattice and stabilizes the OFF states of myosin heads. | Nat Commun | 2024 | 38521794 | PubTator, text mining | PubMed |
| Diagnostic yield from cardiac gene testing for inherited cardiac conditions and re-evaluation of pre-ACMG variants of uncertain significance. | Ir J Med Sci | 2024 | 38489124 | PubTator, text mining | PubMed |
| Bringing into focus the central domains C3-C6 of myosin binding protein C. | Front Physiol | 2024 | 38487262 | PubTator, text mining | PubMed |
| Translating myosin-binding protein C and titin abnormalities to whole-heart function using a novel calcium-contraction coupling model. | J Mol Cell Cardiol | 2024 | 38462126 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4607/papers?page=14